Autoimmune Disease: Budget-buster or Enlightened Solutions? (The coming epidemic and the new administration in Washington)

Journal Title: Archives of Community Medicine and Public Health - Year 2017, Vol 3, Issue 1

Abstract

A rising epidemic among Americans threatens to disrupt the new US administration’s promise of affordable health insurance for all. The epidemic consists of a dramatic and ongoing increase in the incidence of autoimmune diseases (AD) across the populations of nearly all Western countries, diagnosed under approximately 100 different disease labels, and currently estimated to afflict up to 50 million Americans. One potential reason for the epidemic appears to be autoimmune reactions in people to immune ‘triggers’ in foods, a prime example of which may be the newly described GMO foods’ antigenic glyphosate-induced misfolded proteins. An analysis was undertaken, using a case study approach, to compare the relative cost/benefit ratios of treating the oncoming AD epidemic among Americans using the standard medicine (SM) pharmaceutical immunosuppression drug treatment model as compared to treating AD using a functional medicine (FM) approach of probiotics, lifestyle modification and improved diet choices along with governmental regulations to reduce consumption of trigger foods. We conclude that, for the American people over the next 10 years, applying only SM could cost up to $2 trillion more than a potentially equally or more effective diagnosis and treatment program emphasizing FM and government action to reduce trigger food consumption and avoid confounding influences from industry. While these two models are not mutually exclusive, our analysis suggests that the US government has a series of difficult choices ahead which will impact both its population’s health and the affordability of their health insurance over the next decade and beyond.

Authors and Affiliations

Beecham James E, Seneff Stephanie

Keywords

Related Articles

Don’t We Need Non-communicable Diseases Block in Government Tertiary Care Hospitals?

Non-communicable Diseases (NCDs) are emerging as the major cause of morbidity and mortality globally. In India, non-communicable diseases (NCDs) contribute to around 5.87 million deaths that account for 60% of all deaths...

Association between Perceived Stress and Asthma Symptoms in Adolescents

Background: Although the effect of psychological stress on asthma has long been suggested, there is little evidence regarding asthma symptoms such as wheezing in relation to perceived stress in adolescents. Objectives: W...

My own patient experience: Learning to walk again like a baby

I had a left monoparalysis during a holiday abroad in July 2005. This narrative shares my experience of getting ill in a foreign country, how it is diffi cult to describe your troubles and, how little is known about the...

A Narrative Review of Natural History of Diseases and Continuity of Care in Family Medicine

Natural history of disease refers to the progression of a disease process in an individual over time. Family medicine has important epidemiological connotations, presenting a unique opportunity to study natural history o...

Development of Community Health Care Networks Utilizing Local Community Centers

Objectives: Japan is expected to become the first super-aging society in the world, and the collapse of the Japanese health care system is becoming a real possibility, due to the aging of the society combined with a sign...

Download PDF file
  • EP ID EP326553
  • DOI 10.17352/2455-5479.000022
  • Views 86
  • Downloads 0

How To Cite

Beecham James E, Seneff Stephanie (2017). Autoimmune Disease: Budget-buster or Enlightened Solutions? (The coming epidemic and the new administration in Washington). Archives of Community Medicine and Public Health, 3(1), 32-40. https://europub.co.uk/articles/-A-326553